681 innovaTV 207 Parts E and F: a phase 2 study of tisotumab vedotin in patients with head and neck squamous cell carcinoma (trial in progress)

• Christine H Chung,
• Lara A Dunn,
• Ibrahima Soumaoro,
• Leonardo Nicacio,
• Dan P Zandberg,
• Douglas Adkins,
• Tanguy Y Seiwert,
• Nabil F Saba,
• Lova Sun,
• Thomas J George,
• William N William,
• Kristi Schmidt

Affiliations

Christine H Chung

Department of Head and Neck-Endocrine Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Lara A Dunn

7 Department of Medicine, Head and Neck Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Ibrahima Soumaoro

11Genmab US, Inc., Oncology, Plainsboro, USA

Leonardo Nicacio

1Seattle Genetics, Inc., Bothell, USA

Dan P Zandberg

UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Douglas Adkins

Washington University School of Medicine, St. Louis, MO, USA

Tanguy Y Seiwert

1Johns Hopkins University School of Medicine, Baltimore, MD, USA

Nabil F Saba

Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia, USA

Lova Sun

3University of Pennsylvania, Philadelphia, PA, USA

Thomas J George

4University of Florida, Gainesville, FL, USA

William N William

7Oncoclinicas, São Paulo, São Paulo, Brazil

Kristi Schmidt

9Seagen Inc., Bothell, WA, USA